Literature DB >> 10838251

Calpain3 expression during human cardiogenesis.

F Fougerousse1, L V Anderson, A L Delezoide, L Suel, M Durand, J S Beckmann.   

Abstract

Transcripts of calpain3, the gene involved in limb girdle muscular dystrophy type 2A, appear in organs other than the skeletal muscle during human development, the first of which being the early embryonic heart. We examined more precisely the spatio-temporal transcription pattern of calpain3 during human cardiogenesis and the appearance of its protein in fetal tissues, and correlated it to titin expression. Different events of the heart's maturation can be recognized: (i) the presence of titin RNA or protein constitute very precocious developmental cardiac markers appearing before the fusion of the two lateral endocardial tubes; (ii) the disappearance of calpain3 RNA from the ventricular compartment later in the embryonic heart. Finally, although calpain3 transcripts are present in the heart, the corresponding protein is not detected elsewhere than in skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10838251     DOI: 10.1016/s0960-8966(99)00107-8

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  9 in total

1.  Six and Eya expression during human somitogenesis and MyoD gene family activation.

Authors:  Françoise Fougerousse; Muriel Durand; Soledad Lopez; Laurence Suel; Josiane Demignon; Charles Thornton; Hidenori Ozaki; Kyoshi Kawakami; Patrick Barbet; Jacques S Beckmann; Pascal Maire
Journal:  J Muscle Res Cell Motil       Date:  2002       Impact factor: 2.698

2.  Titin splicing regulates cardiotoxicity associated with calpain 3 gene therapy for limb-girdle muscular dystrophy type 2A.

Authors:  William Lostal; Carinne Roudaut; Marine Faivre; Karine Charton; Laurence Suel; Nathalie Bourg; Heather Best; John Edward Smith; Jochen Gohlke; Guillaume Corre; Xidan Li; Zaher Elbeck; Ralph Knöll; Jack-Yves Deschamps; Henk Granzier; Isabelle Richard
Journal:  Sci Transl Med       Date:  2019-11-27       Impact factor: 17.956

Review 3.  Proteases in cardiometabolic diseases: Pathophysiology, molecular mechanisms and clinical applications.

Authors:  Yinan Hua; Sreejayan Nair
Journal:  Biochim Biophys Acta       Date:  2014-05-09

4.  Tibial muscular dystrophy is a titinopathy caused by mutations in TTN, the gene encoding the giant skeletal-muscle protein titin.

Authors:  Peter Hackman; Anna Vihola; Henna Haravuori; Sylvie Marchand; Jaakko Sarparanta; Jerome De Seze; Siegfried Labeit; Christian Witt; Leena Peltonen; Isabelle Richard; Bjarne Udd
Journal:  Am J Hum Genet       Date:  2002-07-26       Impact factor: 11.025

5.  Stressing the giant: a new approach to understanding dilated cardiomyopathy.

Authors:  Marion Lewis Greaser
Journal:  J Mol Cell Cardiol       Date:  2009-06-22       Impact factor: 5.000

Review 6.  Regulation and physiological roles of the calpain system in muscular disorders.

Authors:  Hiroyuki Sorimachi; Yasuko Ono
Journal:  Cardiovasc Res       Date:  2012-04-27       Impact factor: 10.787

7.  Myocardial strain analysis using cardiac magnetic resonance in patients with calpainopathy.

Authors:  Marian Christoph; Felix M Heidrich; Silvio Quick; Max Winkler; Uwe Speiser; Karim Ibrahim; Jochen Schäfer; Axel Linke; Kun Zhang
Journal:  Orphanet J Rare Dis       Date:  2021-04-30       Impact factor: 4.123

Review 8.  CAPN3: A muscle‑specific calpain with an important role in the pathogenesis of diseases (Review).

Authors:  Lin Chen; Fajuan Tang; Hu Gao; Xiaoyan Zhang; Xihong Li; Dongqiong Xiao
Journal:  Int J Mol Med       Date:  2021-09-22       Impact factor: 4.101

9.  Cardiopulmonary dysfunction in patients with limb-girdle muscular dystrophy 2A.

Authors:  Madoka Mori-Yoshimura; Kazuhiko Segawa; Narihiro Minami; Yasushi Oya; Hirohumi Komaki; Ikuya Nonaka; Ichizo Nishino; Miho Murata
Journal:  Muscle Nerve       Date:  2016-12-30       Impact factor: 3.217

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.